Skip to content
OpenCapital
Get started

Progyny PGNY Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$912M+0.6%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
——

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%
Enterprise value$2B-29.6%
P/E31.1×-23.9×
P/S1.6×-0.8×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's available for sale securities debt securities current?
Progyny (PGNY) reported available for sale securities debt securities current of $93.5M in Q1 2026.
How has Progyny's available for sale securities debt securities current changed year-over-year?
Progyny's available for sale securities debt securities current decreased by 36.3% year-over-year, from $146.88M to $93.5M.
What is the long-term trend for Progyny's available for sale securities debt securities current?
Over 5 years (2020 to 2025), Progyny's available for sale securities debt securities current has grown at a 38.4% compound annual growth rate (CAGR), from $38.99M to $197.86M.